SpyBiotech
Biotechnology ResearchView the employees at
SpyBiotech-
Mark Leuchtenberger Chief Executive Officer, SpyBiotech Ltd.
-
Cambridge, Massachusetts, United States
-
Rising Star
Rebecca Moore Senior Scientist-
Oxford, England, United Kingdom
-
Rising Star
Imran Hussain Experienced Clinical Research Professional-
Greater Southampton Area
-
Rising Star
Jeanette Wagener Senior Scientist Immunology at SpyBiotech-
Oxford, England, United Kingdom
-
Rising Star
Overview
SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases. SpyBiotech was spun out of the University of Oxford in 2017. Its proprietary protein superglue technology binds antigens to vaccine delivery platforms in a way which minimizes delivery risk and enhances immunogenicity and efficacy. The company’s current lead candidate is against human cytomegalovirus (HCMV), with clinical studies planned for this year.
-